Pfizer Buying Cardiovascular Biopharma Company – IOTW Report

Pfizer Buying Cardiovascular Biopharma Company

National Pulse

Pfizer is about to buy Arena Pharmaceuticals for $6.7 billion. Arena is a biopharmaceutical company focused in part on cardiovascular and inflammatory medicines to a global patient cohort. A majority of mainstream news outlets have focused their reportage on Arena’s bowel disease treatment, while failing to mention the firm’s cardiovascular research. More

8 Comments on Pfizer Buying Cardiovascular Biopharma Company

  1. Of course they are. It would be news if they were not engaging in what they have also tipped off their “friends” in government positions that are mandating everyone take the shots of this “opportunity” to get rich quick.

    6
  2. Gee, guess they’re learning from their government buds. Create a problem. step in with a solution.

    Lather, rinse, repeat ad infinitum.

    They’re not looking to get people healthy, they want customers. Israel is about to mandate the 4th shot and we’re being told that booster shots could eventually become monthly.

    As long tens of millions of young adults are turned over to the teacher’s unions, there will always be a market for their evil idiocy.

    4
  3. Create Heart inflammation, buy Arena Pharmaceuticals who concentrate on cardiovascular and inflammatory medicines.
    Purchased for $6.7 BILLION.

    Future earnings for PFIZER $10s of Billions of dollars treating what they caused with their vaccine which was created and bought with our tax dollars.

    Hell of a deal !

    6

Comments are closed.